Page last updated: 2024-08-24

coproporphyrin i and Breast Neoplasms

coproporphyrin i has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, IT; Cheeti, S; Chen, B; Cheung, KWK; Liu, L; Morley, R; Sahasranaman, S; Yoshida, K1

Trials

1 trial(s) available for coproporphyrin i and Breast Neoplasms

ArticleYear
GDC-0810 Pharmacokinetics and Transporter-Mediated Drug Interaction Evaluation with an Endogenous Biomarker in the First-in-Human, Dose Escalation Study.
    Drug metabolism and disposition: the biological fate of chemicals, 2019, Volume: 47, Issue:9

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Biomarkers; Breast Neoplasms; Cinnamates; Coproporphyrins; Dose-Response Relationship, Drug; Drug Interactions; Feasibility Studies; Female; Half-Life; Humans; Indazoles; Liver-Specific Organic Anion Transporter 1; Middle Aged; Receptors, Estrogen; Solute Carrier Organic Anion Transporter Family Member 1B3

2019